Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05903196 · ClinicalTrials.gov registry record · NA
Radiofrequency Ablation Study in LatinX Patients
A NA study of Thyroid Nodule, sponsored by Northwell Health.
- Recruiting
- Registry status
- NA
- Development phase
- 44
- Enrollment target
- 1
- Study location
NCT05903196: Recruiting NA study of Thyroid Nodule, sponsored by Northwell Health.
NCT05903196 is a NA study of Thyroid Nodule that is actively recruiting participants, run by Northwell Health. The registered enrollment target is 44 participants, below the 75-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (41% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05903196, a NA study of Thyroid Nodule, is actively recruiting participants, sponsored by Northwell Health.
- RECRUITING
- Registry status
- NA
- Development phase
- 44 participants
- Enrollment target
- 1
- Study location
Study Summary
Benign thyroid nodules can still create cosmetic, compressive, or hormonal issues for patients. In the past, surgery was typically used to treat thyroid nodules causing the above issues through partial or complete thyroidectomy. More recently, minimally-invasive techniques have been developed to treat these issues. This study is investigating the use of one of these techniques, radiofrequency ablation, in Latinx patients with benign symptomatic thyroid nodules. This procedure is of interest because it avoids the risks of surgery and can be done outside an operating room. The study hypothesis is that the use of RFA is an effective and safe therapeutic option for LatinX patients with a symptomatic benign nodule wishing to avoid surgery.
Primary Outcome
To study the change in nodule volume
Conditions Studied
Interventions
- DEVICE Mygen V-1000 RF system
Study Locations (1)
New York
- Northwell Health Physician Partners - New York
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 44 participants |
| Start Date | 2024-03-12 |
| Est. Completion | 2025-12-30 |
| Phase | NA |
What NCT05903196 shows while recruiting
NCT05903196 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 44 participants, a relatively small participant target, below the 75-participant average among 5 other Thyroid Nodule trials with a reported enrollment target (41% lower).
The record links to 1 condition, with Thyroid Nodule appearing as the primary indexed condition, and to 1 intervention - of which Mygen V-1000 RF system is the first listed.
NCT05903196 reports a single indexed study location in New York.
Frequently Asked Questions
What is clinical trial NCT05903196 about?
NCT05903196 is a clinical study titled "Radiofrequency Ablation Study in LatinX Patients". Benign thyroid nodules can still create cosmetic, compressive, or hormonal issues for patients. In the past, surgery was typically used to treat thyroid nodules causing the above issues through partial or complete thyroidectomy. More recently, minimally-invasive techniques have been developed to tre...
What is the current status of trial NCT05903196?
This trial is currently recruiting. It is a NA study. The enrollment target is 44 participants. The study started on 2024-03-12. Estimated completion is 2025-12-30.
What conditions does trial NCT05903196 study?
This clinical trial studies the following conditions: Thyroid Nodule.
What interventions are being tested in trial NCT05903196?
The interventions under investigation include: Mygen V-1000 RF system (DEVICE).
Who is sponsoring clinical trial NCT05903196?
This trial is sponsored by Northwell Health, which has 370 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05903196 being conducted?
This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Thyroid Nodule
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
A Study of Multiparametric Ultrasound Imaging Methods
RECRUITING · NA
-
Prospective Evaluation of the Pulse Biosciences nPulse™ Vybrance™ Percutaneous Electrode System
RECRUITING · NA
-
TRAIL Study: Feasibility and Pilot
RECRUITING · NA
-
Decision Aid and Thyroid Nodules Management
RECRUITING · NA
-
Diagnostic Accuracy of Shear-Wave Elastography for the Preoperative Risk Stratification of Follicular Lesions of the Thyroid
COMPLETED · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02323945 · 44 participants · NA
Effects of Breathing Mild Bouts of Low Oxygen on Limb Mobility After Spinal Injury
- NCT03093909 · 44 participants · Phase 1
Study of Aerosol Gemcitabine in Patients With Solid Tumors and Pulmonary Metastases
- NCT03104491 · 44 participants · Phase 1
Inotuzumab Ozogamicin Post-Transplant For Acute Lymphocytic Leukemia
- NCT03781765 · 44 participants · Phase 4
Stimulant vs. Non-stimulant Treatments and Reward Processing in Drug-naive Youth at SUD Risk
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI